Results 91 to 100 of about 79,183 (269)

Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong, Sarah Hillman, Sharon Dixon, Anupa Shah, Radha Venkatakrishnan, Jeremy W. Tomlinson   +5 more
wiley   +1 more source

Regional Hereditary Cancer Program in Chile: A scalable model of genetic counseling and molecular diagnosis to improve clinical outcomes for patients with hereditary cancer across Latin America

Biological Research
Background Breast cancer is a leading cause of cancer-related mortality worldwide, with hereditary forms accounting for approximately 10% of cases. In Chile, significant gaps exist in genetic counseling and testing, particularly within the public health ...
Natalia Landeros, Laura Vargas-Roig, Silvina Denita, Alejandra Mampel, Rafael Hasbún, Hernán Araya, Iván Castillo, Camila Valdes, Marcela Flores, Juan Salgado Salter, Katherin Vasquez, Jacqueline Romero, Ramón Pérez-Castro   +12 more
doaj   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas, Olivia Carere, Lauren Clarfield, Michelle Jacobson   +3 more
wiley   +1 more source

CLINICAL AND BIOCHEMICAL ASPECTS OF THE USE OF MAGNESIUM IN OBSTETRICS, GYNECOLOGY AND PERINATOLOGY

Акушерство, гинекология и репродукция, 2016
Significant biochemical role of magnesium in the body is well-known, as well as good proven clinical efficacy of magnesium in obstetrics and gynecology.
K. Dadak, A. D. Makatsariya, D. V. Blinov, U. V. Zimovina   +3 more
doaj  

Harmonizing Distributed Data in Aquatic Sciences: Key Takeaways from the 2026 ASLO‐SIL Workshop

Limnology and Oceanography Bulletin, EarlyView.
Robert T. Hensley, Bennett J. McAfee, Michael F. Meyer, Katalin Patonai, Nicolas Harrison, Kaelin M. Cawley, Frieda B. Taub, Mireia Bartrons, Asena Goren, Hans‐Peter Grossart   +9 more
wiley   +1 more source

“Hello, these people exist”: Examining dietitians' perspectives, approaches, and experiences in transgender and gender diverse health

Nutrition &Dietetics, EarlyView.
Abstract Aim The lack of research and guidelines on transgender and gender diverse health, including nutrition considerations, contributes to negative health outcomes for transgender and gender diverse people. This study sought to examine dietitians' perspectives, knowledge, and experiences regarding transgender and gender diverse health dietetic ...
Majella Jones, Christie Bennett, Julia McCartan, Janeane Dart   +3 more
wiley   +1 more source

The Additive Effect of Risedronate, a Bisphosphonate, on the Bone Mineral Density (BMD) in Osteopenic Postmenopausal Women Treated with Long-term Hormone Replacement Therapy (HRT) and the Long-term HRT Effect on the BMD in Older Postmenopausal Women [PDF]

近年,強力な骨吸収抑制作用を持つビスフォスフォネート製剤が骨粗鬆症の治療に使用されている.長期間(3年以上,平均±SE:6.0±1.2年)のホルモン補充療法(hormone replacement therapy:HRT)を施行中の骨量減少患者を対象にリセドロネート2.5mg/日を投与し[Risedronate (Ris)+HRT群, n=11],投与前と投与後42ヶ月間, 6ヶ月に1回,骨密度(bone mineral density:BMD)を測定した.また ...
ハマダ, ヨシノブ, 濱田, 佳伸, Hamada, Yoshinobu   +2 more
core   +1 more source

A population-based cohort study of HRT use and breast cancer in Korea

, 2012
The incidence of breast cancer has recently been ranked first in Korea. This is a population-based cohort study that aims to evaluate the risk of breast cancer from the use of hormone replacement therapy (HRT).
Lee, SY, Shin, HR, Park, SB
core   +1 more source

Differences in Habitat Quality Drive Behavioral Contrasts in Two Family Groups of the Critically Endangered Hainan Gibbon (Nomascus hainanus)

Integrative Zoology, EarlyView.
Habitat quality variation drove distinct behavioral strategies: GC (resource‐rich group) behaviors were influenced by food availability, safety and stability, while GE (resource‐scarce group) behaviors relied more on topography, food, and nutrients. Seasonal behavioral flexibility was demonstrated, with food variables dominating in the dry season and ...
Shuai Liu, Dexu Zhang, Eric I. Ameca, Guangyu Wang, Chenglin Cai, Wenxing Long, Yuan Chen, Shrestha Anil   +7 more
wiley   +1 more source

Combined Contrast Enhanced Mammography and Digital Breast Tomosynthesis in Patients Suspected of Having Breast Cancer: A Prospective Comparison With Digital Mammography and Breast MRI—Findings of the CONTEST Study

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction We aimed to assess diagnostic performance and accuracy for local staging of CEM combined with DBT (CE + DBT) compared to digital mammography (DM) and MRI. Methods Female patients aged 18–70 years with clinical or sonographic suspicion of breast cancer had CE + DBT and breast MRI prior to treatment.
Sarah L. Savaridas, Kulsam Ali, Sarah Vinnicombe, Petra Rauchhaus, Andrew J. Evans, Nisha Sharma, Sally Bolt, Patsy Whelehan   +7 more
wiley   +1 more source